Delivery Order SPE2DB22D3016-SPE2DB25FAUN2
Award Date
4/23/25
Potential Completion Date
4/24/25
Potential Value
$7.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,146,222 units of the prescription medication Ondansetron HCL 4 mg tablets. The contract has a firm fixed price of $27,923.30 and a completion date of May 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,895.46, is for the delivery of 4,568,077,758 units of Ondansetron HCl 4 mg tablets in 30-count packages. The contract is a firm-fixed price delivery order, with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,116.51 contract is for the supply of 4,559,438,684 units of Ondansetron HCL 4 mg tablets. The contract has a period of performance through December 22, 2022 and was awarded on December 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,134,278 tablets of the medication Ondansetron HCL 4 mg. The contract has a firm fixed price of $3,805.07 and a completion date of May 6, 2025. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,678.96, is for the delivery of 4,567,873,264 units of the medication Ondansetron ODT 4 mg tablet. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,891.13, is for the supply of 4,567,826,790 units of the medication Ondansetron ODT 4 mg tablet. The contract is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,977.03 firm fixed-price contract is for the delivery of 4,567,875,611 units of the prescription medication Ondansetron HCL 4 mg tablet. The contract has an ultimate completion date of April 11, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, with a total ceiling value of $3,608.26 and a period of performance ending on April 18, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,359.93, is for the delivery of 4,568,096,130 units of the medication Ondansetron ODT 4 mg tablet in 30-count packaging. The contract is a firm fixed-price, non-set-aside arrangement with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,581.89 contract is for the delivery of 4,568,126,790 units of the medication Ondansetron HCL 8 mg tablets. The order has a completion date of May 6, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive vehicle for supplying a wide range of...